Predictors and consequences of severe hypoglycemia in adults with diabetes : a systematic review of the evidence

Prevalence of type 2 diabetes is increasing at an alarming pace, fueled by the rising rates of overweight and obesity in many populations. In the VA healthcare system, the prevalence of diabetes was 20% in fiscal year 2000 and is now estimated at nearly 25%. Although people with diabetes have a subs...

Full description

Main Author: Bloomfield, Hanna E.
Corporate Authors: Quality Enhancement Research Initiative (U.S.), Minneapolis VA Health Care System (U.S.) VA Evidence Synthesis Program
Format: eBook
Language:English
Published: [ Washington : D.C.] Department of Veterans Affairs [2012], 2012
Series:Evidence-based synthesis program
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02835nam a2200325 u 4500
001 EB000943571
003 EBX01000000000000000737161
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
100 1 |a Bloomfield, Hanna E. 
245 0 0 |a Predictors and consequences of severe hypoglycemia in adults with diabetes  |h Elektronische Ressource  |b a systematic review of the evidence  |c prepared for Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service ; prepared by Evidence-based Synthesis Program (ESP) Center, Minneapolis VA Medical Center ; investigators: principal investigator, Hanna E. Bloomfield ... [et al.] 
260 |a [ Washington : D.C.]  |b Department of Veterans Affairs  |c [2012], 2012 
300 |a 1 PDF file (iii, 163 p.  |b ill.) 
505 0 |a Includes bibliographical references 
653 |a Glucose / deficiency 
653 |a Hypoglycemia / etiology 
653 |a Risk Factors 
653 |a Diabetes Mellitus, Type 2 / complications 
653 |a Blood Glucose 
710 2 |a Quality Enhancement Research Initiative (U.S.) 
710 2 |a Minneapolis VA Health Care System (U.S.)  |b VA Evidence Synthesis Program 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Evidence-based synthesis program 
500 |a "April 2012." 
856 |u https://www.ncbi.nlm.nih.gov/books/NBK114893  |3 Volltext 
082 0 |a 610 
520 |a Prevalence of type 2 diabetes is increasing at an alarming pace, fueled by the rising rates of overweight and obesity in many populations. In the VA healthcare system, the prevalence of diabetes was 20% in fiscal year 2000 and is now estimated at nearly 25%. Although people with diabetes have a substantially increased risk of cardiovascular disease (CVD), recent trials show that intensive glucose lowering does not reduce the risk of CVD death or all-cause mortality although it reduces the risk of microvascular complications (nephropathy, retinopathy and neuropathy) and possibly non-fatal myocardial infarction. Intensive glucose control also increases the risk of hypoglycemic episodes. Several recent meta-analyses of the trials comparing intensive to conventional glucose control concluded that intensive control is associated with a 2-2.5 fold increased risk of severe hypoglycemia. The reviews however have not included smaller randomized trials, trials focused on the comparison of specific drug regimens, and non-randomized trials. We conducted the current review to provide broader insight into the incidence of, the risk factors for, and the clinical and social impact of severe hypoglycemia in adults with type 2 diabetes treated with glucose lowering medications